171 related articles for article (PubMed ID: 38146590)
1. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
[TBL] [Abstract][Full Text] [Related]
2. Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy.
Dali CÍ; Barton NW; Farah MH; Moldovan M; Månsson JE; Nair N; Dunø M; Risom L; Cao H; Pan L; Sellos-Moura M; Corse AM; Krarup C
Ann Clin Transl Neurol; 2015 May; 2(5):518-33. PubMed ID: 26000324
[TBL] [Abstract][Full Text] [Related]
3. Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial.
Í Dali C; Sevin C; Krägeloh-Mann I; Giugliani R; Sakai N; Wu J; Wasilewski M
Mol Genet Metab; 2020; 131(1-2):235-244. PubMed ID: 32792226
[TBL] [Abstract][Full Text] [Related]
4. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
5. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
6. Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study.
Í Dali C; Groeschel S; Moldovan M; Farah MH; Krägeloh-Mann I; Wasilewski M; Li J; Barton N; Krarup C
Ann Clin Transl Neurol; 2021 Jan; 8(1):66-80. PubMed ID: 33332761
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS assays to quantify sulfatides and lysosulfatide in cerebrospinal fluid of metachromatic leukodystrophy patients.
Cao KH; Zhang G; Jacobsen L; Wu J
Bioanalysis; 2020 Nov; 12(22):1621-1633. PubMed ID: 33151743
[No Abstract] [Full Text] [Related]
8. [Pathophysiology of sulfatide metabolism in metachromatic leukodystrophy].
Wiesmann UN
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):33-47. PubMed ID: 27269
[TBL] [Abstract][Full Text] [Related]
9. Improved synthesis of [1-14C]acyl-sphingosine-galactose-3-sulfate (sulfatide) for diagnosis of metachromatic leukodystrophy: usefulness of radioscanning.
Masson M; Li WX; Fluharty AL; Beaucourt JP; Turpin JC; Baumann N
Clin Chim Acta; 1991 Sep; 201(3):157-68. PubMed ID: 1684534
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
Blomqvist M; Gieselmann V; Månsson JE
Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
[TBL] [Abstract][Full Text] [Related]
12. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
[TBL] [Abstract][Full Text] [Related]
13. A variant form of metachromatic leukodystrophy without arylsulfatase deficiency.
Hahn AF; Gordon BA; Hinton GG; Gilbert JJ
Ann Neurol; 1982 Jul; 12(1):33-6. PubMed ID: 6126151
[TBL] [Abstract][Full Text] [Related]
14. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
15. Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy.
Toda K; Kobayashi T; Goto I; Ohno K; Eto Y; Inui K; Okada S
J Neurochem; 1990 Nov; 55(5):1585-91. PubMed ID: 1976756
[TBL] [Abstract][Full Text] [Related]
16. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
17. A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy.
Saravanan K; Büssow H; Weiler N; Gieselmann V; Franken S
J Neurosci Methods; 2007 Apr; 161(2):223-33. PubMed ID: 17204333
[TBL] [Abstract][Full Text] [Related]
18. Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue.
Poduslo SE; Tennekoon G; Price D; Miller K; McKhann GM
J Neuropathol Exp Neurol; 1976; 35(6):622-32. PubMed ID: 11278
[TBL] [Abstract][Full Text] [Related]
19. Lysosulfatide (galactosylsphingosine-3-O-sulfate) from metachromatic leukodystrophy and normal human brain.
Rosengren B; Fredman P; Månsson JE; Svennerholm L
J Neurochem; 1989 Apr; 52(4):1035-41. PubMed ID: 2926387
[TBL] [Abstract][Full Text] [Related]
20. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity.
Molzer B; Sundt-Heller R; Kainz-Korschinsky M; Zobel M
Am J Med Genet; 1992 Nov; 44(4):523-6. PubMed ID: 1359786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]